Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.
Journal: American journal of respiratory and critical care medicine
Published: August 11, 2025
Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment.
Journal: European journal of drug metabolism and pharmacokinetics
Published: July 31, 2022
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.
Journal: Diabetes, obesity & metabolism
Published: September 21, 2018
The effects of short-term and long-term testosterone supplementation on blood viscosity and erythrocyte deformability in healthy adult mice.
Journal: Endocrinology
Published: March 17, 2015
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms.
Journal: Bioorganic & medicinal chemistry letters
Published: January 13, 2014
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimization.
Journal: Bioorganic & medicinal chemistry letters
Published: January 07, 2014
Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: October 26, 2013
Last Updated: 09/26/2026